The Shanghai company, which owns two old brands, Lei Yunshang and Kaikai, had revenue of 670 million yuan last year

2022-06-21 0 By

Shanghai Kaikai Industry Co., LTD. (hereinafter referred to as “Kaikai Industry”), which owns two time-honored brands “Lei Yunshang” and “Kaikai”, recently released the 2021 annual report. During the report period, the company achieved operating revenue of 670 million yuan, down 12.08% year-on-year;Net profit attributable to shareholders of listed companies reached 21.7172 million yuan, up 58.81% year-on-year.By December 31, 2021, kaikai industrial assets total 1.062 billion yuan, compared with the balance of 1.043 billion yuan at the end of last year, an increase of 19.5022 million yuan, an increase of 1.87%.During the reporting period, Kaikai Industry realized the main business income of 642 million yuan, down 12.31% compared with the same period last year.The pharmaceutical sector achieved revenue of 579 million yuan from its main business, down 11.29% year-on-year, and the gross margin of its main business was 25.05%, up 0.31 percentage points from the same period last year.The main business income of the garment industry was 58.2122 million yuan, down 23.56% year on year, and the gross profit margin of the main business was 12.43%, up 3.37 percentage points compared with the same period last year.In the pharmaceutical sector, the company achieved revenue of 579 million yuan from its main business in 2021, down 11.29% year-on-year, and the gross margin of its main business was 25.05%, up 0.31 percentage points from the same period last year.According to the annual report, the business are greatly influenced by health care policy, in the face of national drug quantity purchase for advancing, new GPO implementation of regionalization and slow disease strengths party policy cancelled, such as the depth of the medicare drug policy effect, and the 2020 outbreak, leading to the new medicine circulation revenue decline year by year, the new face unfavorable conditions for the adoption of countermeasures actively, adjust the structure of sales,It reduced the proportion of sales of low-margin products.In terms of clothing sector, the company achieved main business revenue of 58.2122 million yuan in 2021, down 23.56% year on year, and the gross margin of main business was 12.43%, up 3.37 percentage points year on year.According to the annual report, due to the impact of international trade, the operating revenue and profitability of the sector have suffered a significant negative impact under the double blow of foreign trade orders loss and the epidemic.Although we tried to make up the revenue gap of foreign trade processing business by increasing domestic trade processing business, the effect was not obvious.Therefore, since April 2021, the company has carried out comprehensive reform of the foreign trade processing sector through a series of measures such as business adjustment and personnel structure optimization, and incurred large comprehensive reform costs in that year.By the end of 2021, Kaikai Industrial owns 23 self-operated retail stores (one of which is a combination of self-owned property and rental property), with a floor area of 5,371.87 square meters, all of which are located in Jing ‘an District, Shanghai.In order to further optimize store layout and improve operation quality, the company will close 4 pharmaceutical retail stores in 2021.Kaikai said that in recent years, the company has been affected by the market environment, changes in medical reform policies and repeated epidemic, and its operating revenue has declined year by year, affecting the company’s profitability.At the same time, in order to fully implement the strategic transformation of “big health”, the company tries to explore the expansion and cultivation of the three core business segments of pharmaceutical health, medical health and medical care health. However, the business transformation needs a long incubation period, and it is difficult to boost the company’s profit growth in the short term.Open industrial affiliated business are greatly influenced by health care policy, medicine plate facing the national drug with quantity purchase for advancing, new GPO implementation of regionalization and slow disease strengths party policy cancel medical drugs such as the depth of influence, in 2020 and outbreaks, leading to the new medicine circulation revenue decline year by year, the new in the face of unfavorable conditions for the adoption of countermeasures actively,Adjusted the sales structure and reduced the proportion of low – profit products.The garment business of Kaikai Industry is affected by international trade. Under the double blow of foreign trade order loss and the epidemic, its operating revenue and profitability are significantly negatively affected.Although we tried to make up the revenue gap of foreign trade processing business by increasing domestic trade processing business, the effect was not obvious.Therefore, since April 2021, the company has carried out comprehensive reform of the foreign trade processing sector through a series of measures such as business adjustment and personnel structure optimization, and incurred large comprehensive reform costs in that year.During the reporting period, we opened the two key words of “refinement” and “reduction” of the Garment Association, and closely focused on the main work line of “grasping reform and operation at the same time”, made efforts to improve the quality of retail operation and expand group purchase customization business:On the one hand, on the basis of the successful completion of the comprehensive reform of the industry and trade sector, according to the actual situation of its own business development, it explored the idea of the fixed staffing and post of the trade sector, refined the accuracy of the adaptation of personnel and posts, and promoted the implementation of the comprehensive reform plan.On the other hand, in the context of the downturn in the garment industry and the shrinking of the national garment production and sales, Kaikai Clothing has adjusted the product structure of its business in the national garment market by focusing on the development of new products, the selection of fabrics, the style version and the market pricing, focusing on the middle and high-end products and greatly reducing the low-end series of products.Combined with product positioning, we will explore new retail models, steadily promote group buying business, increase e-commerce marketing and promotion, do a good job in brand publicity, and actively seek new development space.Further strengthen the brand system construction, try the national brand authorization business transformation pilot, so as to encourage dealers to expand sales business, to ensure the stability of brand income.In 2021, Kaikai Garment responded to and participated in the “Chao •GO Jing ‘an” fashion broadcast studio, and opened the brand through new media platform;To meet the demands of fast-paced life, we launched a new series of ready-to-wear shirts;Combined with the climate characteristics of winter and spring alternation, the new development of “cashmere + mulberry silk” silk scarf series products;Develop standard version of the new men’s jacket series.Opened shaanxi North Road store shortlisted as “Shanghai Gift Preferred Store”;”Kaikaihai Group Fan” series, kaikai” New State tide “leader style cuff nail gift box two products shortlisted in” 2021 Shanghai Preferred Features Companion Gift List “(gold list);Kaikai Series of Fragrant cloud silk scarves participated in the 100 “Yangtze River Delta Characteristic Hand Gift” selection in Shanghai, Zhejiang, Jiangsu and Anhui provinces and ranked in the list;Kaikai brand won the honor of “2021 Shanghai First Economic Leading local Brand” and so on.Through continuous brand promotion activities, the social influence of the brand has been continuously expanded.Kaikai industry said that in 2022, the company will continue to promote the big health transformation strategy and innovation of business development mode, and seek new economic growth point.The company will continue to enhance the endogenous business structure optimization, and actively explore new means of capital enabling business adjustment, effectively use the platform value of listed companies, further optimize the main business structure, so that high-quality resources to gather advantage industries.To continue to increase investment in health business as the core, actively looking for new profit growth point, increase the company’s core competitiveness, to lay a solid foundation for the company’s long-term development, including:New to strengthen, on the basis of the existing business, will gradually enrich other formats, constantly trying to expand medical sector business layout, firmly grasp the “digital health as a whole the lead, the coordinated development of medicine, medical treatment, medical raise the trinity” the strategy of “three vertical and three horizontal” the main line, continuous power structure adjustment “supply side” and “demand side” industry transformation.Along with the reform of medical insurance personal accounts, “double track” New Deal, hospital prescribing information and pharmacy connectivity and other measures to boost consumption information, in order to adapt to the policy environment and consumer demand changes, the new will attempt by optimizing product structure, strengthen characteristic experience, cultivate new consumer groups, the rich and diversified, with the aid of digital information and intelligent means,Explore new retail markets with online and offline connectivity, and accelerate the shift speed of retail chains;Further expand new specialty drug products and channels, give full play to the comprehensive service effect of “infusion integrated”, and achieve sustainable development of business scale;Explore the possibility of setting up self-run medical institutions, combine the operation mode of specialized medical service project management and personnel training, plan and build modern specialized medical projects, create new highlights of medical service, and help the company take a key step in the transformation of big health.At the same time, in the domestic COVID – 19 when sending out the outbreak, and jing an Internet cloud hospital pharmacy accelerated online doctors visits, promoting and cultivating the consumer to buy drug habit, to meet the needs of online consulting under the situation of significant growth, perfecting the “cloud” pharmacy service level, explore “cloud mall” model docking, meet people through various channels, consumer demandBoost lexi “digital health” development to a higher level.Kaikai Clothing will focus on the main line of “reform and efficiency enhancement”, while completing the comprehensive reform of the industry and trade sector, timely start and promote the comprehensive reform of the trade sector.Continue to strengthen the development of group purchase cooperation business, actively look for partners with strong marketing strength, good team management basis and good product and service quality, take the initiative to find a multi-channel cooperation mode, to develop new space for business development.At the same time, Kaikai clothing will also strengthen the management and control of brand authorization business, improve the effect of brand management, and maintain the brand market image;Foreign reasonably adjust distribution (agent), sales area and team, to speed up the national sales regional business integration, further carding dealer base and shuffle, try characteristics according to the sales area, supporting the expansion of emerging distribution agent team, break the logjam in the original area distributor monopoly business, phasing out some business shrink and expand the stagnant dealer,Try to grab market share.Tell the brand stories of “Made in Shanghai”, “time-honored brands” and “Domestic products”, plan to explore the added value effect of corresponding products, and convert the achievements of brand building into new economic growth points.Public information shows that Kaikai Industry is mainly engaged in traditional Chinese medicine circulation, traditional Chinese medicine services (TRADITIONAL Chinese medicine consultation services) and clothing wholesale and retail. The “Kaikai” brand owned by the company was founded in 1936. Among them,The pharmaceutical sector is mainly engaged in the wholesale and retail of Chinese and Western patent medicines, as well as the sales of traditional Chinese medicine pharmaceutical care under the brand of “Lei Yunshang” and its own brand of “Shang Lei” high-grade tonic.The clothing sector is mainly engaged in the wholesale and retail of shirts and woolen sweaters under the Chinese time-honored “Kaikai” brand and clothing series under the “Kaikai” brand.As of the first textile network this evening before the last trading day, Kaikai Industrial closed at 9.60 yuan/share, up 0.21%, market value of 2.333 billion yuan.(Martin, First Textile Web)